HEC Pharm Co., Ltd.

Pharmaceutical division of the HEC group, with its production base in Yidu, Yichang. It reports a macrolide plant certified by the US FDA, the European Union, the WHO and the Chinese agency, an oseltamivir plant and recombinant glargine and aspart insulins. The group, founded in 1997 and headquartered in Dongguan, runs seven production bases.